Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Brain, Behavior, and Immunity|April 19, 2011
Fatigued breast cancer survivors and gene polymorphisms in the inflammatory pathwayKristin V Reinertsen, Grethe I Grenaker Alnæs, Hege Landmark-Høyvik, et al.Psycho-Oncology|October 16, 2008
Fear of recurrence in long-term testicular cancer survivorsTone Skaali, Sophie D Fosså, Roy Bremnes, et al.BMC Cancer|December 25, 2012
Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention studyMarit Synnestvedt, Elin Borgen, Erik Wist, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancerJohanna Sjöström, Carl Blomqvist, Kristina von Boguslawski, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2010
Phase III randomized study comparing docetaxel plus trastuzumab with vinorelbine plus trastuzumab as first-line therapy of metastatic or locally advanced human epidermal growth factor receptor 2-positive breast cancer: the HERNATA studyMichael Andersson, Elisabeth Lidbrink, Karsten Bjerre, et al.Acta Oncologica (Stockholm, Sweden)|May 7, 2002
Physical performance, toxicity, and quality of life as assessed by the physician and the patientMinna-Liisa Luoma, Liisa Hakamies-Blomqvist, Johanna Sjöström, et al.British Journal of Cancer|November 8, 2018
Metabolite and lipoprotein responses and prediction of weight gain during breast cancer treatmentTorfinn S Madssen, Inger Thune, Vidar G Flote, et al.International Journal of Cancer|June 4, 2020
Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER-positive breast cancerHedda von der Lippe Gythfeldt, Tonje Lien, Xavier Tekpli, et al.Breast Cancer Research and Treatment|October 24, 2017
Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trialGabe S Sonke, Lowell L Hart, Mario Campone, et al.Genome Medicine|December 1, 2018
Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrationsElen Kristine Höglander, Silje Nord, David C Wedge, et al.Pageof 4